Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q2 2025 · 10-Q
Revenue$7.50K$7.50K±0.0% vs Q2 2024 Net Income$5.06K$5.06KN/M vs Q2 2024 EPS Diluted$0.00$0.00— vs Q2 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Operating Cash Flowderived-$19,142N/M Margins · derivedGross margin1.9%−6.4 pt vs Q2 2024
Operating margin-1230.8%−554.8 pt vs Q2 2024
Net margin67.5%+798.1 pt vs Q2 2024
ended Nov 30, 2024 · filed Jan 13, 2025 · 44 d after period end